lgA nephropathy - Human disease and animal model

Renal Failure

Volumn 19, Issue 3, 1997, Pages 347-371

  Endo, Yuzo ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

Animal models; IgA nephropathy; Pathogenesis; Review

Indexed keywords

IMMUNOGLOBULIN A;

ANAPHYLACTOID PURPURA; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTHUS PHENOMENON; B LYMPHOCYTE; CHRONIC GLOMERULONEPHRITIS; CHRONIC KIDNEY FAILURE; HEMATURIA; HEPATITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE COMPLEX DEPOSITION; IMMUNOGLOBULIN A NEPHROPATHY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; REVIEW; ANIMAL; DISEASE MODEL; IMMUNOLOGY; LIVER CIRRHOSIS; LUNG DISEASE; PATHOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; LIVER CIRRHOSIS; LUNG DISEASES;

EID: 0030610772     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229709047722     Document Type: Review

References (193)

1. Berger J, Hinglais N: Les depots intercapillaires d'IgA-IgG. J Urol Nephrol 74:694-695, 1968.
2. Berger J: IgA glomerular deposits in renal disease. Transplant Proc 1:939-944, 1969.
3. Hara M, Endo Y, Nihei H, Hara S, Fukushima O, Mimura N: IgA nephropathy with subendothelial deposits. Virchows Arch A 386:249-263, 1980.
4. Johnston RA, Brown JS, Braumholtz DA, Davison AM: Clinico-pathological correlations and long-term follow-up of 253 United Kingdom patients with IgA nephropathy: a report from the MRC glomerulonephritis registry. Q J Med (New Ser) 84:619-627, 1992.
5. Ibels LS, Gyoery AZ: IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine 73:79-102, 1994.
6. Emancipator SN, Lamm ME: Biology of disease. IgA nephropathy: pathogenesis of the most common form of glomerulonephritis. Lab Invest 60:168-183, 1989.
7. Shirai T, Tomino Y, Yoshiki T, Itoh T: IgA nephropathy: clinicopathology and immunopathology. Contr Nephrol 9:88-100, 1978.
8. D'Amico G: The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med (New Ser) 64:709-727, 1987.
9. Van Es LA: Pathogenesis of IgA nephropathy. Kidney Int 41:1720-1729, 1992.
10. Endo Y, Kanbayashi H: Etiology of IgA nephropathy syndrome. Pathol Int 44:1-13, 1994.
11. Emancipator SN: Current concepts in renal pathology. IgA nephropathy: morphologic expression and pathogenesis. Am J Kidney Dis 23:451-462, 1994.
12. Galla JH: IgA nephropathy. Kidney Int 47:377-387, 1995.
13. Nakamoto Y, Asano Y, Dohi K, Fujioka M, Iida H, Kida H, Kibe Y, Hattori N, Takeuchi J, et al: Primary IgA nephropathy and Schoenlein-Henoch purpura nephritis: clinicopathological and immunohistological characteristics. Q J Med (New Ser) 47:495-516, 1987.
14. Berger J, Yaneva H, Nabarra B: Glomerular changes in patients with cirrhosis of the liver. In Hamburger J, Crosnier J, Grunfeld JP, Maxwell MH (eds), Advances in Nephrology. Chicago, New York Medical Publishers, 1977, vol 7, pp 3-14.
15. Nakamoto Y, Iida H; Kobayashi K, Dohi H, Kida H, Hattori N, Takeuchi J: Hepatic glomerulonephritis: characteristics of hepatic IgA glomerulonephritis as the major part. Virchows Arch (Pathol Anat) 392:45-54, 1983.
16. Endo Y, Matsushita H, Nozawa Y, Nishikage S, Matsuya S, Hara M: Glomerulonephritis associated with liver cirrhosis. Acta Pathol Jpn 33:333-346, 1986.
17. Kawaguchi K, Koike M: Glomerular lesions associated with liver cirrhosis: an immunohistochernical and etiopathologic analysis. Human Pathol 17:1137-1143, 1986.
18. Woodroffe AJ, Clarkson AR, Seymour AE, Lomax-Smith JD: Mesangial IgA nephritis. Springer Semin Immunopathol 5:321-332, 1982.
19. Moorthy AV, Zimmerman SW, Maxim PE: Dermatitis herpetiformis and celiac disease: association with glomerulonephritis, hypocomplementemia and circulating immune complexes. J Am Med Assoc 239:2019-2020, 1978.
20. Katz A, Dyck RF, Bear RA: Celiac disease associated with immune complex glomerulonephritis. Clin Nephrol 11:39-44, 1979.
21. Endo Y, Hara M: Glomerular IgA deposition in pulmonary diseases. Kidney Int 29:557-562, 1986.
22. Silva FG, Hogg RJ: IgA nephropathy. In Tisher CC, Brenner BM (eds), Renal Pathology with Clinical and Functional Correlations. Philadelphia, J. B. Lippincott, 1989, pp 434-493.
23. Clarkson AR, Woodroffe AJ, Bannister KM, Lomax-Smith JD, Aarons I: The syndrome of IgA nephropathy. Clin Nephrol 21:7-14, 1984.
24. Sinniah R: Occurrence of mesangial IgA and IgM deposits in a control necropsy population. J Clin Pathol 36:276-279, 1983.
25. Underdown BJ, Schiff JM: Immunoglobulin A: strategic defense initiative at the mucosal surface. Ann Rev Immunol 4:389-417, 1986.
26. Mestecky J, McGhee JR: Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol 40:153-245, 1987.
27. Tomasi TB, Tan EM, Solomon A, Prendergast RA: Characteristics of an immune system common to certain external secretions. J Exp Med 121:101-121, 1965.
28. Delacroix DL, Grubb A, Kobayashi K, Fujiyama Y, Rits M, Vaerman J-P: New data on the structure and metabolism of human serum IgA: a new IgA-protease, protein HC-IgA complexes and the importance of intravascular IgA. In Revillard J-P, Voisin N, Wierzbicki N (eds), Local Immunity. International Symposium Series. Mucosal Immunology. IgA and Polymorphonuclear Neutrophils. Suresnes, Cedex (France), Fondation Franco-Allemande, 1985, pp 60-68.
29. Fujihashi K, McGhee JR, Lue C, Beagley KW, Taga T, Hirano T, Kishimoto T, Mesteckey J, Kiyono H: Human appendix B cells naturally express receptors for and respond to interleukin 6 with selective IgA1 and IgA2 synthesis. J Clin Invest 88:248-252, 1991.
30. Sonoda E, Hitoshi Y, Yamaguchi N, Ishii T, Tominaga A, Araki S, Takatsu Y: Differential regulation of IgA production by TGF-β induces surface IgA-positive cells bearing IL-5 receptor, whereas IL-5 promotes their survival and maturation into IgA-secreting cells. Cell Immunol 140:158-172, 1992.
31. Kimata H, Fujimoto M: Induction of IgA1 and IgA2 production in mature human fetal B cells and pre-B cells by vasoactive intestinal peptide. Blood 58:2098-2104, 1995.
32. Kerr MA: Review article. The structure and function of human IgA. Biochem J 271:285-296, 1990.
33. Koshland ME: The coming of age of the immunoglobulin J chain. Ann Rev Immunol 3:425-454, 1985.
34. Mostov KE, Friedlander M, Blobel G: The receptor for transepithelial transport of IgA and IgM contains multiple immunoglobulin-like domains. Nature (Lond.) 308:37-43, 1984.
35. Brown WR, Isobe Y, Nakane PK: Studies on translocation of immunoglobulins across intestinal epithelium. II. Immunoelectron microscopic localization of immunoglobulins and secretory component in human intestinal mucosa Gastroenterology 71:981-995, 1976.
36. Fisher MM, Nagy B, Bazin H, Underdown BJ: Biliary transport of IgA: role of secretory component. Proc Natl Acad Sci USA 76:2008-2012, 1979.
37. Schiff JM, Fisher MM, Underdown BJ: Secretory component as the mucosal transport receptor: separation of physicochemically analogous human IgA fractions with different receptor binding capacities. Mol Immunol 23:45-56, 1986.
38. Tsuzukida Y, Wang C-C, Putnam FW: Structure of the A2m(1) allotype of human IgA - a recombinant molecule. Proc Natl Acad Sci USA 76:1104-1108, 1979.
39. Tomana M, Kulhavy R, Mestecky J: Receptor-mediated binding and uptake of immunoglobulin A by human liver. Gastroenterology 94:762-770, 1988.
40. Brown WR, Kloppel TM: The liver and IgA: immunological, cell biological and clinical implications. Hepatology 9:763-784, 1989.
41. Roque-Barreira MC, Campos-Neto A: Jacalin: an IgA binding lectin. J Immunol 134:1740-1743, 1985.
42. Fujiyama Y, Kobayashi K, Senda S, Benno Y, Bamba T, Hosoda S: A novel IgA protease from Clostridium sp. capable of cleaving IgA1 and IgA2 A2m(1) allotype but not IgA2 A2m(2) allotype paraproteins. J Immunol 134:573-576, 1985.
43. Monteiro R, Kubagawa H, Cooper MD: Cellular distribution, regulation, and biochemical mature on an Fcα receptor in humans. J Exp Med 171:597-613, 1990.
44. Bienenstock J, Befus AD: Mucosal immunology. Immunology 41:249-270, 1980.
45. Nagura H: Mucosal defense mechanism in health and disease: role of the mucosal immune system. Acta Pathol Jpn 42:387-400, 1992.
46. Dunkley M, Pabst R, Cripps A: An important role for intestinally developed T cells in respiratory defense. Immunol Today 16:231-236, 1995.
47. Crago SS, Kutteth WH, Moro I, Allansmith MR, Radle J, Haajiman JJ, Mestecky J: Distribution of IgA1-IgA2-, and J-chain-containing cells in human tissues. J Immunol 132:16-19, 1984.
48. Ko Y.-C, Itoh Y, Monden S, Kobayashi K, Kawai T: Serum IgA subclass in Japanese: preparation of monoclonal antibody, epitope mapping and clinical application. In Tuchiya M et al. (eds), Frontiers of Mucosal Immunology, vol 1. Elsevier Science, 1991, pp 215-218.
49. Baart De La Faille-Kuyper EH, Katel L, Kruijten RH: Occurrence of vascular IgA deposits in clinically normal skin of patients with renal disease. Kidney Int 9:424-429, 1976.
50. Lamperi S, Carozzi S: Skin-muscle biopsy in patients with various nephropathies. Nephron 24:46-50, 1979.
51. Harland RW, Backer CG, Brandes JC, Fritsche C, Rosenzweig DY: Immunoglobulin A (IgA) immune complex pneumonitis in a patient with IgA nephropathy. Ann Intern Med 116:220-222, 1992.
52. Valentijn RM, Kauffmann RH, Brutel de la Riviere G, Dana MR, Van Es LA: Presence of circulating macromolecular IgA in patients with hematuria due to primary IgA nephropathy. Am J Med 74:375-381, 1983.
53. Czerkinsky C, Koopman WJ, Jackson S, Collins JE, Crago SS, Schroehenloher RE, Julian BA, Galla JH, Mesteckey J: Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathy. J Clin Invest 77:1931-1938, 1986.
54. Berger J, Yaneva H, Nabarra B, Barbanel C: Recurrence of mesangial deposition of IgA after renal transplantation. Kidney Int 7:232-241, 1975.
55. Silva FG, Chander P, Pirani CL: Disappearance of glomerular mesangial IgA deposits after renal allograft transplantation. Transplantation 33:214-216, 1982.
56. Sanfilippo F, Croker BP, Bollinger RB: Fate of four cadaveric donor renal allografts with mesangial IgA nephropathy. Transplantation 33:370-376, 1982.
57. Rifai A, Small PA, Teague PO, Ayoub EM: Experimental IgA nephropathy. J Exp Med 150:1161-1173, 1979.
58. Hale GM, McIntosh SL, Hiki Y, Clarkson AR, Woodroffe AJ: Evidence for IgA specific B cell hyperactivity in patients with IgA nephropathy. Kidney Int 29:718-724, 1986.
59. Feehally J, Beattie TJ, Brenchley PEC, Coupes BM, Mallick NP, Postlethwaite RJ: Sequential study of the IgA system in relapsing IgA nephropathy. Kidney Int 30:924-931, 1986.
60. Newkirk M, Klein MH, Katz A, Fisher MM, Underdown BJ: Estimation of polymeric IgA in human serum: an assay based on binding of radiolabeled human secretory component with applications in the study of IgA nephropathy, IgA monoclonal gammopathy, and liver cirrhosis. J Immunol 130:1176-1181, 1983.
61. Rifai A, Schena P, Montinaro V, Mele M, D'Addabbo A, Nitti L, Pezzullo JC: Clearance kinetics and fate of macromolecular IgA in patients with IgA nephropathy. Lab Invest 61:381-388, 1989.
62. Roccatello D, Picciotto G, Ropolo R, Coppo R, Quattrochio G, Cacace G, Molino A, Amoroso A, Baccega M, Isidoro C, Cardosi R, Sena LM, Piccoli G: Kinetics and fate of IgA-IgG aggregates as a model of naturally occurring immune complexes in IgA nephropathy. Lab Invest 66:86-95, 1992.
63. Conley ME, Cooper M, Michael A: Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis and systemic lupus erythematosus. J Clin Invest 66:3432-1436, 1980.
64. Mestecky J, Tomana M, Crowley-Nowick PA, Moldoveanu Z, Julian BA, Jackson S: Defective galactosylation and clearance of IgA molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib Nephrol 104:172-182, 1993.
65. Coppo R, Basado B, Piccoli G, Mazzucco G, Bulzomi MR, Roccatello D, De Marchi M, Carbonara AO, Barbiano di Belgiojoso G: IgA1 and IgA2 immune complexes in primary IgA nephropathy and Henoch-Schoenlein nephritis Clin Exp Immunol 57:583-590, 1984.
66. Coppo R, Arico S, Piccoli G, Basolo B, Roccatello D, Amore A, Tabone M, De La Pierre M, Sessa A, Delacroix DL, Vaerman JP: Presence and origin of IgA1 and IgA2-containing circulating immune complexes in chronic alcoholic liver diseases with and without glomerulonephritis. Clin Immunol Immunopathol 35:1-8, 1985.
67. Endo Y, Matsushita H, Matsuya S, Kara M: A study of human interstitial lung diseases with special reference to immune complexes and hyaline membrane. Acta Pathol Jpn 40:239-248, 1990.
68. Couser WG, Salant DJ: In situ immune complexes formation and glomerular injury. Kidney Int 17:1-13, 1980.
69. van Damme BJCP: Studies of Mechanisms of Deposition of Immune Complexes in Experimental Glomerulonephritis. Brussels, Arscia Uitgaven, 1977.
70. Haakenstad AO, Striker GE, Mannik M: The glomerular deposition of soluble immune complexes prepared with reduced and alkylated antibodies and with intact antibodies in mice. Lab Invest 35:293-301, 1976.
71. Haakenstad AO, Striker GE, Mannik M: The disappearance kinetics and glomerular deposition of small-latticed soluble immune complexes. Immunology 47:407-414, 1982.
72. Mannik M, Arend WP, Hall AP, Gilliland BC: Studies on antigen-antibody complexes. 1. Elimination of soluble complexes from rabbit circulation. J Exp Med 133:713-739, 1971.
73. Gauthier VJ, Mannik M, Striker GE: Effect of cationized antibodies in preformed immune complexes on deposition and persistence in renal glomeruli. J Exp Med 156:766-777, 1982.
74. Gallo GR, Caulin-Glaser T, Lamm ME: Charge of circulating immune complexes as a factor in glomerular basement membrane localization. J Clin Invest 67:1305-1313, 1981.
75. Oite T, Batsford SR, Mihatsch MJ, Takamiya H, Vogt A: Quantitative studies of in situ immune complex glomerulonephritis in the rat induced by planted, cationized antigen. J Exp Med 155:460-474, 1982.
76. Koyama A, Inage H, Kobayashi M, Ohya Y, Narita M, Tojo S, Cameron JS: Role of antigenic charge and antibody avidity on the glomerular immune complex localization in serum sickness of mice. Clin Exp Immunol 64:606-614, 1986.
77. Michael AF, Keane WF, Raij L, Vernier RL, Mauer SM: The glomerular mesangium. Kidney Int 17:141-154, 1980.
78. Isaacs KL, Miller F: Role of antigen size and charge in immune complex glomerulonephritis. 1. Active induction of disease with dextran and its derivatives. Lab Invest 47:198-205, 1982.
79. Gauthier VJ, Striker GE, Mannik M: Glomerular localization of preformed immune complexes prepared with anioaic antibodies or with cationic antigens. Lab Invest 50:636-644, 1984.
80. Hara M, Honda K, Matsuya S, Endo Y, Hara S, Suzuki Y: The juxtaglomerular apparatus in IgA nephropathy: an analysis of the transport and fate of IgA deposits at the glomerular hilus. Virchows Arch A Pathol Anat 413:431-443, 1988.
81. Elma JD, Hoyer JR, Vernier RL: The glomerular mesangium: uptake and transport of intravenously injected colloidal carbon in rats. Kidney Int 9:395-406, 1976.
82. Leiper JM, Thomson D, MacDonald MK: Uptake and transport of Imposil by the glomerular mesangium in the mouse. Lab Invest 37:526-533, 1977.
83. Michael AF, Keane WF, Raij L, Vernier RL, Mauer SM: The glomeruiar mesangium. Kidney Int 17:141-154, 1980.
84. Menefee MG, Mueller CB, Bell AL, Myers JK: Transport of globin by the renal glomerulus. J Exp Med 120:1129-1138, 1964.
85. Cederholm B, Wieslander J, Bygren P, Heinegard D: Patients with IgA nephropathy have circulating anti-basement membrane antibodies reacting with structure common to collagen I, II and IV. Proc Natl Acad Sci USA 83:6151-6155, 1986.
86. Cederholm B, Wieslander J, Bygren P, Heinegard D: Circulating complexes containing IgA and fibronectin in patients with primary IgA nephropathy. Proc Natl Acad Sci USA 85:4865-4868, 1988.
87. Coppo R, Amore A, Gianoglio B, Porcellini MG, Gusumano R, Giani M, Sereni F, Gianviti A, Rizzoni G, Murer L, Zachello G, Pollastro M, Lama G, Caringella A, Li Volti S: Macromolecular IgA and abnormal IgA reactivity in sera from children with IgA nephropathy. Clin Nephrol 43:1-13, 1995.
88. Imai H, Wakui H, Ishino T, Komatsuda A, Nakamoto Y, Miura AB, Kobayashi R: Glomerular deposition of complex-forming glycoprotein heterogeneous in charge (protein HC) in IgA nephropathy. Clin Nephrol 37:169-176, 1992.
89. Latta H, Maunsbach AB: Relations of the centrolobular region of the glomerulus to the juxtaglomerular apparatus. J Ultrastruct Res 6:562-578, 1962.
90. Miller GW: Solubilization of IgA immune precipitates by complement. J Immunol 117:1374-1377, 1976.
91. Tomino S, Sakai H, Suga T, Miura M, Kaneshige H, Endoh M, Nomoto Y: Impaired Solubilization of glomerular immune deposits by sera from patients with IgA nephropathy. Am J Kidney Dis 3:48-53, 1983.
92. Schifferli JA, Steiger G, Hauptmann G, Spaeth PJ, Sjoeholm AG: Formation of soluble immune complexes by complement in sera of patients with various hypocomplementemic states. J Clin Invest 76:2127-2133, 1985.
93. Spaeth PJ, Pascual M, Meyer-Hanni L, Schaad UB, Schifferli SA: Solubilization of immune precipitates by complement in the absence of Properdin or Factor D. FEBS Lett 234:131-134, 1988.
94. Williams JD, Czop JK, Abrahamson DR, Davies M, Austen KF: Activation of the alternative complement pathway by isolated human glomerular basement membrane. J Immunol 133:394-399, 1984.
95. Gomez-Guerrero C, Gonzalelz E, Egido J: Evidence for a specific IgA receptor in rat and human mesangial cells. J Immunol 151:7172-7181, 1993.
96. Tornroth MD: The fate of subepithelial deposits in acute poststreptococcal glomerulonephritis. Lab Invest 35:461-474, 1976.
97. Cohen AH, Border WA, Glassock RJ: Nephrotic syndrome with glomerular mesangial IgM deposits. Lab Invest 38:610-619, 1978.
98. Couser WG, Baker PJ, Adler S: Complement and the direct mediation of immune glomerular injury: a new perspective. Kidney Int 28:879-890, 1985.
99. Falk RJ, Dalmasso AP, Kim Y, Tsai CH, Sheinman JI, Gewurz H, Michael AF: Neoantigens of the polymerized ninth component of complement: characterization of a monoclonal antibodies and immunohistochemical localization in renal disease. J Clin Invest 72:560-573, 1983.
100. Yoshioka K, Takemura T, Asano N, Okada M, Yagi K, Maki S, Inai S, Akita H, Koitabashi Y, Takekoshi Y: IgA nephropathy in patients with congenital C9 deficiency. Kidney Int 42:1253-1258, 1992.
101. Hiemstra PS, Gorter A, Stuurman ME, van Es LA, Daha MR: Activation of the alternative pathway of complement by human serum IgA. Eur J Immunol 17:321-326, 1987.
102. Burton DR, Woof JM: Human antibody effector function. Adv Immunol 15:1-84, 1993.
103. Yoshikawa N, Iijima K, Matsuyama S, Suzuki J, Kameda A, Okada S, Nakamura H: Repeat renal biopsy in children with IgA nephropathy. Clin Nephrol 33:160-167, 1990.
104. Rifai A, Chen A, Imai H: Complement activation in experimental IgA nephropathy: an antigen-mediated process. Kidney Int 32:838-844, 1987.
105. Montinaro V, Esparza AR, Cavallo T, Rifai A: Antigen as mediator of glomerular injury in experimental IgA nephropathy. Lab Invest 64:508-519, 1991.
106. Dinarello CA: Biology of interleukin 1. FASEB J 2:108-115, 1988.
107. Horii Y, Muraguchi A, Iwano M, et al: Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol 143:3949-3955, 1989.
108. Nathan CF, Prendergast TJ, Wiebe ME, Stanley ER, Platzer E, Renold HG, Weite K, Rubin BY, Murray HW: Activation of human macrophages: comparison of other cytokines with interferon-gamma. J Exp Med 160:600-605, 1984.
109. Alpers CE, Seifert RA, Hudkins KL, Johnson RJ, Bowen-Pope DF: PDGF-receptor localizes to mesangial, parietal epithelial, and interstitial cells in human and primate kidneys. Kidney Int 43:286-294, 1993.
110. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E: An antiserum against transforming growth factor pi suppresses experimental glomerulonephritis. Nature 346:371-374, 1990.
111. Floege J, Eng E, Linder V, Alpers CE, Youg BA, Reidy MA, Johnson RJ: Rat glomerular mesangial cell synthesize basic fibroblast growth factor: release, upregulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis. J Clin Invest 90:2362-2369, 1992.
112. Oritz A, Alonso J, Gomez-Chiarri M, Lerma JL, Seron D, Condom E, Gonzalez E, Egido J: Fibronectin (FN) decreases glomerular lesions and synthesis of rumor necrosis factor-alpha (TNF-α), platelet-activating factor (PAF) and FN in proliferative glomerulonephritis. Clin Exp Med 101:334-340, 1995.
113. Yoshimura A, Iwasaki S, Inui K, Ideura T, Koshikawa S, Yanagisawa M, Masaki T: Endothelin-1 and endothelin B type receptor are induced in mesangial proliferative nephritis in the rat. Kidney Int 48:1290-1297, 1995.
114. Shigematsu H, Kobayashi Y, Tateno S, Hiki Y, Kuwano S: Ultrastructural glomerular loop abnormalities in IgA nephritis. Nephron 30:1-7, 1982.
115. Kobayashi M, Koyama A, Yamagata K, Yamaguchi N, Narita M, Shigematsu H: Significance of deposits and abnormalities of the glomerular basement membrane in tissue injury accompanying IgA nephropathy, Jpn J Nephrol 34:47-56, 1992.
116. Bennett WM, Kincaid-Smith P: Macroscopic hematuria in mesangial IgA nephropathy: correlation with glomerular crescents and renal dysfunctions. Kidney Int 23:393-400, 1993.
117. Shouno Y, Shimokawa T, Sakemi T, Harada A, Yamaguchi Mq Watanabe T: Segmental glomerular necrosis as an active index of IgA nephropathy: a study with 100 serial sections of 128 cases. Acta Pathol Jpn 43:723-729, 1993.
118. Berthoux F-C, Alamartine E, Pommier C, Lepetit J-C: HLA and IgA nephritis revisited 10 years later: HLA-B35 antigen as prognostic factor. N Engl J Med 319:1609-1610, 1988.
119. Yoshida H, Mitarai T, Kawamura T, Kitajima T, Miyazaki Y, Nagasawa R, Kawaguchi Y, Kubo H, Ishikawa I, Sakai O: Role of the detection polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 96:2162-2169, 1995.
120. Bloodworth JMB, Sommers SC: "Cirrhotic glomemlosclerosis" - a renal lesion associated with hepatic cirrhosis. Lab Invest 8:962-978, 1959.
121. Gormly AA, Smith PS, Seymour AE, Clarkson AR, Woodroffe AJ: IgA glomerular deposits in experimental cirrhosis. Am J Pathol 104:50-54, 1981.
122. Nagura H, Tsutsumi Y, Hasegawa H, et al: IgA plasma cells in biliary mucosa: a likely source of locally synthesized IgA in human hepatic bile. Clin Exp Immunol 54:671-680, 1983.
123. Pittella JEH, Bambirra EA: Immune complexes in the choroid plexus in liver cirrhosis. Arch Pathol Lab Med 115:220-222, 1991.
124. Endo Y: Glomerular changes in liver cirrhosis. Kidney and Dialysis 25:601-609, 1988 (in Japanese).
125. Smith SM, Yu GSM, Tsukamoto H: IgA nephropathy in alcohol abuse: an animal model. Lab Invest 62:179-184, 1990.
126. Takekoshi Y, Tanaka M, Shida N, Satake V, Matsumoto S: Strong association between membranous nephropathy and hepatitis-B surface antigenemia in Japanese children. Lancet 2:1065-1068, 1978.
127. Takekoshi Y, Tanake M, Miyakawa Y, Yoshizawa H, Takahashi K, Mayumi M: Free "small" and IgG-associated "large" hepatitis Be antigen in the serum and glomerular capillary walls of two patients with membranous nephropathy. N Engl J Med 300:814-819, 1979.
128. Ito H, Hattori S, Matsuda I, Amemiya S, Hajikano H, Yoshizawa H, Miyakawa Y, Mayumi M: Hepatitis Be antigen-mediated membranous glomenilonephritis: correlation of ultrastructural changes with HBe Ag in the serum and glomeruli. Lab Invest 44:214-220, 1981.
129. Iida H, Izumino K, Asaka M, et al: Membranoproliferative glomerulonephritis associated with chronic hepatitis B in adults: pathogenetic role of HBs Ag. Am. J Nephrol 7:319-324, 1987.
130. Lai KN, Lai FM, Chan KW, Chow CB, Tong KL, Valtence-Owen J: The clinicopathologic features of hepatitis B virus-associated glomerulonephritis. Q J Med 63:323-333, 1987.
131. Eknoyan G: Glomerular abnormalities in liver disease: hepatitis B virus infection. In Epstein M (ed), The Kidney in Liver Disease, 4th ed. Philadelphia, Hanley & Belfus, 1996, pp 123-151.
132. Magil A, Webber D, Chou V: Glomerulonephritis associated with hepatitis B surface antigenemia: report of a case with features of both membranous and IgA nephropathy. Nephron 42:335-339, 1986.
133. Johnson RJ, Gretch DR, Yamabe H, et al: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328:465-470, 1993.
134. Brouet J-C, Clauvel J-P, Danon F, Klein M, Seligmann M: Biologic and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 57:775-788, 1974.
135. Agnello V, Chung RT, Kaplan LM: A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327:1490-1495, 1992.
136. Tomana M, Kulhavy R, Mestecky J: Receptor-mediated binding and uptake of immunoglobulin A by human liver. Gastroenterology 94:762-770, 1988.
137. Ashwell G, Harford J: Carbohydrate-specific receptors of the liver. Ann Rev Biochem 51:531-554, 1982.
138. Nagura H, Smith PD, Nakane PK, Brown WR: IgA in human bile and liver. J Immunol 126:587-595, 1981.
139. Waxman FJ, Hebert LA, Cosio FG, et al: Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. J Clin Invest 77:82-89, 1986.
140. Roccatello D, Picciotto G, Coppo R, et al: Clearance of polymeric IgA aggregates in humans. Am J Kidney Dis 14:354-360, 1989.
141. Bene MC, Faure G, Hurault de Ligny B, Kessler M, Duheille J: Immunoglobulin A nephropathy: quantitative immunohistomorphometry of the tonsillar plasma cells evidences an inversion of the immunoglobulin A versus immunoglobulin G secreting cell balance. J Clin Invest 7:1342-1347, 1983.
142. Kusakari C, Nose M, Takasaka T, Yuasa R, Kato M, Miyazono K, Fujita T, Kyougoku M: Immunopathological features of palatine tonsil characteristic of IgA nephropathy: IgA1 localization in follicular dendritic cells. Clin Exp Immunol 95:42-48, 1994.
143. Brandtzaeg P: Immune functions of human nasal mucosa and tonsils in health and disease. In Bienenstock J (ed), Immunology of the Lung and Upper Respiratory Tract. New York, McGraw-Hill, 1984, pp 28-95.
144. Homma H, Yamanaka A, Tanimoto S, Tamura M, Chijimatsu Y, Kira S, Izumi T: Diffuse panbronchiolitis: a disease of the transitional zone of the lung. Chest 83:63-69, 1983.
145. Funakoshi S, Doi T, Nakajima T, Suyama T, Tokuda M: Antimicrobial effect of human serum IgA. Microbial Immunol 26:227-239, 1982.
146. Lowell GH, Smith LF, Griffiss JM, Brandt BL: IgA-dependent monocyte mediated antibacterial activity. J Exp Med 152:452-457, 1980.
147. Tagliabue A, Nencioni L, Villa L, Keren DF, Lowell GH, Borashi D: Antibody-dependent cell-mediated antibacterial activity of intestinal lymphocytes with secretory IgA. Nature 306:184-186, 1983.
148. Braley JF, Peterson LB, Dawson CA, Moore VL: Effect of hypersensitivity on protein uptake across the air-blood barrier of isoiated lung. J Clin Invest 63:1103-1109, 1979.
149. Coppo R, Basolo B, Rollino C, Roccatello D, Martina G, Amore A, Bongiono G, Piccoli G: Mediterranean diet and primary IgA nephropathy. Clin Nephrol 26:72-82, 1986.
150. Fornasieri A, Sinico RA, Maldifossi P, Bernasconi P, Vegni M, D'Amico G: IgA-antigliadin antibodies in IgA mesangial nephropathy (Berger's disease). Br Med J 295:78-80, 1987.
151. Laurent J, Branellec A, Heslan JM, et al: An increase in circulating IgA antibodies to gliadin in IgA mesangial glomerulonephritis. Am J Nephrol 7:178-183, 1987.
152. Nagy J, Scott H, Brandtzaeg P: Antibodies to dietary antigens in IgA nephropathy. Clin Nephrol 29:275-279, 1988.
153. Sato M, Kojima H, Takayama K, Koshikawa S: Glomerular deposition of food antigens in IgA nephropathy. Clin Exp Immunol 73:295-299, 1988.
154. Yap HK, Sakai R, Woo KT, Lim CH, Jordan SC: Bovine serum albumin antigen in circulating immune complexes of patients with IgA nephropathy. Kidney Int 31:183A, 1987.
155. Coppo R, Roccattello D, Amore A, Quatrochio G, Molino A, Gianoglio B, Amoroso A, Bajardi P, Piccoli G: Effects of a gluten-free diet in primary IgA nephropathy. Clin Nephrol 33:72-86, 1990.
156. Jackson S, Moldoveanu Z, Kirk KA, Julian BA, Patterson TF, Jilling T, Mestecky J, Galla JH, et al: IgA-containing immune complexes after challenge with food antigens in patients with IgA nephropathy. Clin Exp Immunol 89:315-320, 1992.
157. Coppo R, Mazzuco G, Martina G, Roccatello D, Amore A, Novara R, Bargoni A, Piccoli G, Sena LM: Gluten-induced experimental IgA glomerulopathy. Lab Invest 60:499-506, 1989.
158. Sategna-Guidetti C, Ferfoglia G, Bruno M, Pulitano R, Roccattello D, Amore A, Coppo R: Do IgA antigliadin and IgA antiendomysium antibodies show there is latent coeliac disease in primary IgA nephropathy? Gut 33:476-478, 1992.
159. Woodroffe AJ, Gormly AA, McKenzie AE, Wooton AM, Thompson AJ, Seymour AE, Clarkson AJ: Immunological studies in IgA nephropathy. Kidney Int 18:366-374, 1980.
160. Drew PA, Nieuwhof WN, Clarkson AR, Woodroffe AJ: Raised IgA antibodies in patients with IgA nephropathy. Clin Exp Immunol 60:124-129, 1987.
161. Nagy J, Uj M, Szucs G, Trinn C, Burger J: Herpes virus antigens and antibodies in kidney biopsies and sera of IgA glomerulonephritic patients. Clin Nephrol 21:259-262, 1984.
162. Gregory MC, Hammond ME, Brewer ED: Renal deposition of cytomegalovirus antigen in immunoglobulin-A nephropathy. Lancet i:11-15, 1988.
163. Tomino Y, Sakai H, Endoh M: Cross-reactivity of IgA antibodies between renal mesangial area and nuclei of tonsillar cells in patients with IgA nephropathy. Clin Exp Immunol 51:605-610, 1983.
164. Davin JC, Malaise M, Foidart J, Mahieu P: Anti-alpha-galactosyl antibodies and immune complexes in children with Henoch-Schoenlein purpura or IgA nephropathy. Kidney Int 31:1132-1139, 1987.
165. Rostoker G, Petit-Phar M, Delprato S, et al: Mucosal immunity in primary glomerulonephritis: II. Study of the serum IgA subclass repertoire to food and airborne antigens. Nephron 59:561-566, 1991.
166. Suzuki S, Nakatomi Y, Sato H, Tsukada H, Arakawa M: Haemophilus parainfluenzae antigen and antibody in renal biopsy samples and serum of patients with IgA nephropathy. Lancet 343:12-16, 1994.
167. Nomoto Y, Suga T, Miura M, Nomoto H, Tomino Y, Sakai H: Characterization of an acidic nuclear protein recognized by autoantibodies in sera from patients with IgA nephropathy. Clin Exp Immunol 65:513-519, 1986.
168. Sinico RA, Forasieri A, Oreni N, Benuuzzi S, D'Amico G: Polymeric IgA rheumatoid factor in idiopathic IgA mesangial nephropathy (Berger's disease). J Immunol 137:536-541, 1986.
169. Gonzalez-Cabrero J, de Nicolas P, Hernand L: Expression and synthesis of cross-reactive idiotypic antibodies by peripheral blood lymphocytes and their suppression by anti-idiotypes in patients with IgA nephropathy. J Immunol 147:4162-4166, 1991.
170. Schena FP, Pastore A, Ludovico N, Sinico RA, Benuzzi S, Montinaro V: Increased serum levels of IgA1-IgG immune complexes and anti-F(ab')2 antibodies in patients with primary IgA nephropathy. Clin Exp Immunol 77:15-20, 1989.
171. Matsiota P, Dosquet P, Louzir H, Druet E, Druet P, Avrameas S: IgA polyspecific autoantibodies in IgA nephropathy. Clin Exp Immunol 79:361-366, 1990.
172. Markham Jr RV, Sutherland JC, Mardiney MR: The ubiquitous occurrence of immune complex localization in the renal glomeruli of normal mice. Lab Invest 29:111-120, 1973.
173. Iskander SS, Jennete C, Wilkman AS, Becker RL: Interstram variations in nephritogenicity of heterologous protein in mice. Lab Invest 46:344-351, 1982.
174. Eisen HN, Simms ES, Potter M: Mouse myeloma proteins with antihapten antibody activity: the protein produced by plasma cell tumor MOPC-315. Biochemistry 7:4126-4134, 1968.
175. Potter M: Immunoglobulin producing tumors and myeloma proteins of mice. Physiol Rev 52:631-719, 1972.
176. Endo Y, Kanbayashi H, Hara M: Experimental immunoglobuun A nephropathy induced by gram-negative bacteria. Nephron 65:196-205, 1993.
177. Chen A, Sheu L-F, Ding S-L, Lee W-H: Monomeric immunoglobulin A protects glomerulus against polymeric immunoglobulin A immune complex in experimental immunoglobulin A nephropathy. Lab Invest 74:737-746, 1996.
178. Potter M, Leon MA: Three IgA myeloma immunoglobulins from the BALB/c mouse: precipitation with pneumococcal C polysaccharide. Science 162:369-371, 1968.
179. Chen A, Ding S-L, Sheu L-F, Song Y-B, Shieh S-D, Shaio M-F, Chou W-Y, Ho Y-S: Experimental IgA nephropathy: enhanced deposition of glomerular IgA immune complex in proteinuric states. Lab Invest 70:639-647, 1994.
180. Imai H, Chen A, Endoh M, Rifai A: Influence of the antigen on experimental IgA nephropathy. Semin Nephrol 7:283-285, 1987.
181. Isaacs KI, Miller F: Role of antigen size and charge in immune complex glomerulonephritis. II. Passive induction of immune deposits with immune deposits with dextran-antidextran immune complexes. Am J Pathol 111:298-306, 1983.
182. Isaacs KL, Miller F: Role of antigen size and charge in immune complex glomerulonephritis. I. Active induction of disease with dextran and its derivatives. Lab Invest 47:198-205, 1982.
183. Jessen RH, Emancipator SN, Jacobs GH, Nedrud JG: Experimental IgA-IgG nephropathy induced by a viral respiratory pathogen: dependence on antigen form and immune status. Lab Invest 67:379-386, 1992.
184. Potter M: Mouse IgA myeloma proteins that bind polysaccharide antigens of enterobacterial origin. Fed Proc 29:85-91, 1970.
185. Kantor AB: A new nomenclature for B cells. Immunol Today 12:389-391, 1991.
186. Murakami T, Tsubata T, Shinkura R, Nisitani S, Okamoto M, Yoshioka H, Usui T, Miyawaki S, Honjo T: Oral administration of LPS activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induced autoimmune symptoms in an autoantibody transgenic mouse. J Exp Med 180:111-121, 1994.
187. Kroese FGM, Butcher EC, Stall AM, Lalor PA, Adams S, Herzenberg LA: Many of the IgA producing plasma cells in murine gut are derived from self-replenishing precursors in the peritoneal cavity. Int Immunol 1:75-84, 1989.
188. Beagley KW, Bao S, Ramsay AJ, Eldridge JH, Husband AJ: IgA production by peritoneal cavity B cells is IL-6 independent: implications for intestinal IgA response. Eur J Immunol 25:2123-2126, 1995.
189. Tamura SI, Ito Y, Asanuma H, Hirabayashi Y, Suzuki Y, Nagamine T, Aizawa C, Kurata T: Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. J Immunol 149:981-988, 1992.
190. Challacombe SJ, Tomasi TB: Systemic tolerance and secretory immunity after oral immunization. J Exp Med 152:1459-1472, 1980.
191. Gesualdo L, Lamm ME, Emancipator SN: Defective oral tolerance promotes nephritogenesis in experimental IgA nephropathy induced by oral immunization. J Immunol 145:3684-3691, 1990.
192. Imai H, Nakamoto Y, Asakura K, Miki K, Yasuda T, Miura AB: Spontaneous glomerular IgA deposition in ddY mice: an animal model of IgA nephritis. Kidney Int 27:756-761, 1985.
193. Vandenbark AA, Hashim G, Offner H: Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 341:541-544, 1989.